- Home
- FENG vs CALC Comparison
FENG vs CALC Comparison
Compare FENG & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- CALC
- Stock Information
- Founded
- FENG 1998
- CALC 2011
- Country
- FENG China
- CALC United States
- Employees
- FENG N/A
- CALC N/A
- Industry
- FENG Broadcasting
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- CALC Health Care
- Exchange
- FENG Nasdaq
- CALC Nasdaq
- Market Cap
- FENG 37.6M
- CALC 44.7M
- IPO Year
- FENG 2011
- CALC N/A
- Fundamental
- Price
- FENG $2.43
- CALC $3.35
- Analyst Decision
- FENG
- CALC Strong Buy
- Analyst Count
- FENG 0
- CALC 4
- Target Price
- FENG N/A
- CALC $19.50
- AVG Volume (30 Days)
- FENG 5.8K
- CALC 89.5K
- Earning Date
- FENG 11-12-2024
- CALC 11-13-2024
- Dividend Yield
- FENG N/A
- CALC N/A
- EPS Growth
- FENG N/A
- CALC N/A
- EPS
- FENG N/A
- CALC N/A
- Revenue
- FENG $99,426,474.00
- CALC N/A
- Revenue This Year
- FENG N/A
- CALC N/A
- Revenue Next Year
- FENG N/A
- CALC N/A
- P/E Ratio
- FENG N/A
- CALC N/A
- Revenue Growth
- FENG N/A
- CALC N/A
- 52 Week Low
- FENG $1.20
- CALC $2.68
- 52 Week High
- FENG $4.15
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- FENG 41.29
- CALC 40.56
- Support Level
- FENG $2.41
- CALC $3.35
- Resistance Level
- FENG $2.98
- CALC $3.60
- Average True Range (ATR)
- FENG 0.18
- CALC 0.26
- MACD
- FENG -0.03
- CALC -0.03
- Stochastic Oscillator
- FENG 19.67
- CALC 4.35
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.